The rand gave back all of Monday’s gains on Tuesday as the euphoria over a possible coronavirus vaccine faded, with investors now cautious about the details regarding its preparation and distribution.
On Monday, news emerged that a vaccine developed by US pharmaceutical giant Pfizer in partnership with BioNTech was showing good results in the testing phase.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.
faded with the euphoria of a Biden win?
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: